drugset / Trial / NCT01879332
A Sequential Multiple Ascending Dose Study of the Safety and Pharmacokinetics of Eslicarbazepine Acetate in Adult Healthy Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Randomized, double-blind, placebo-controlled, sequential multiple ascending dose study to determine a maximum tolerated dose
Timeline
- Start
- 2006-12
- Primary completion
- 2007-02
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eslicarbazepine acetate | Unknown | 3000 mg | Oral |
| Subject | Eslicarbazepine acetate | Unknown | 3600 mg | Oral |